These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25675969)

  • 21. Intellectual property issues in a clinical trial: a corporate perspective.
    Fersko RS; Connolly MJ
    Qual Assur; 1992 Jun; 1(3):237-48. PubMed ID: 1344679
    [No Abstract]   [Full Text] [Related]  

  • 22. Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act.
    Colaianni A; Cook-Deegan R
    Milbank Q; 2009 Sep; 87(3):683-715. PubMed ID: 19751286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can we expect to achieve anything from Indian Bayh Dole?
    Janodia MD; Sreedhar D; Ligade VS; Udupa N
    Indian J Med Res; 2009 Oct; 130(4):487. PubMed ID: 19942757
    [No Abstract]   [Full Text] [Related]  

  • 24. NIH denies march-in rights on Norvir patent.
    Harrison C
    Nat Rev Drug Discov; 2013 Dec; 12(12):898. PubMed ID: 24287772
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulating scientific research: intellectual property rights and the norms of science.
    Rai AK
    Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815
    [No Abstract]   [Full Text] [Related]  

  • 26. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act.
    Berman EP
    Soc Stud Sci; 2008 Dec; 38(6):835-71. PubMed ID: 19227798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antibiotic pipeline.
    Kunin CM
    N Engl J Med; 2004 Nov; 351(19):2019-20. PubMed ID: 15525731
    [No Abstract]   [Full Text] [Related]  

  • 28. Subverting U.S. health.
    Los Angeles Times; 2003 Dec; ():M4. PubMed ID: 14971390
    [No Abstract]   [Full Text] [Related]  

  • 29. Keeper of the stem cells.
    Lemonick MD
    Time; 2001 Aug; 158(8):57. PubMed ID: 11534482
    [No Abstract]   [Full Text] [Related]  

  • 30. NIH funding for patents that contribute to market exclusivity of drugs approved 2010-2019 and the public interest protections of Bayh-Dole.
    Ledley FD; Cleary EG
    PLoS One; 2023; 18(7):e0288447. PubMed ID: 37494368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayh-Dole: almost 25.
    Kennedy D
    Science; 2005 Mar; 307(5714):1375. PubMed ID: 15746390
    [No Abstract]   [Full Text] [Related]  

  • 32. Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and business.
    Fernandes M; Miska D
    Biotechnol Genet Eng Rev; 2004; 21():249-76. PubMed ID: 17017036
    [No Abstract]   [Full Text] [Related]  

  • 33. Who owns federally funded research? The Supreme court and the Bayh-Dole act.
    Kesselheim AS; Rajkumar R
    N Engl J Med; 2011 Sep; 365(13):1167-9. PubMed ID: 21879888
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmaceutical industry must take its medicine.
    Macilwain C
    Nature; 2011 Feb; 470(7333):141. PubMed ID: 21307893
    [No Abstract]   [Full Text] [Related]  

  • 35. Science and the law. Working through the patent problem.
    Walsh JP; Cohen WM; Arora A
    Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
    [No Abstract]   [Full Text] [Related]  

  • 36. The Human Genome Project: a public good.
    Hudson K
    Health Matrix Clevel; 2002; 12(2):367-75. PubMed ID: 12430360
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug patents. Universities, NIH hear the price isn't right on essential drugs.
    Marshall E
    Science; 2001 Apr; 292(5517):614-5. PubMed ID: 11330302
    [No Abstract]   [Full Text] [Related]  

  • 38. Petition fails to reverse massive price rise for AIDS drug.
    Check E
    Nature; 2004 Aug; 430(7001):715. PubMed ID: 15306778
    [No Abstract]   [Full Text] [Related]  

  • 39. The NIH-Industry New Therapeutic Uses Pilot Program: Demonstrating the Power of Crowdsourcing.
    Colvis CM; Austin CP
    Assay Drug Dev Technol; 2015; 13(6):297-8. PubMed ID: 26241208
    [No Abstract]   [Full Text] [Related]  

  • 40. Capitalizing on commercialization: should congress revisit the Bayh-Dole Act?
    Bruckbauer S
    J Natl Cancer Inst; 2003 Oct; 95(19):1429-31. PubMed ID: 14519745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.